Head and Neck Cancer Trial, Recruiting (NCT07396259)

Head and Neck Cancer Trial, Recruiting NCT07396259 Sponsor: Chang Gung Memorial Hospital Condition: Head and Neck Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07396259 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Head And Neck Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with cancer:

Adults aged 18 or older who have been diagnosed with Head and Neck Cancer and are planning to receive immunotherapy treatment
People whose doctor has assessed their life expectancy to be at least 3 months
People who have a tissue biopsy available, or existing tissue test results for certain cancer markers (called PD-L1 TPS and/or PD-L1 CPS), held at the participating hospital

For healthy participants (no cancer):

Adults aged 18 or older who have never been diagnosed with any type of cancer

Who may not be able to join:

People who have a diagnosed psychiatric (mental health) disorder
People who have uncontrolled medical complications or other serious health conditions
People who have difficulty with blood draws, or who are unwilling to attend scheduled follow-up blood collection appointments
People whose doctor assesses them as unsuitable for participation in the study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hung-Ming Wang, Division of Oncology, Chang Gung Memorial Hospital

Phone: +886975368112

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07396259

Sponsor: Chang Gung Memorial Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Head and Neck Cancer

Trial contact: +886975368112

More information: https://clinicaltrials.gov/study/NCT07396259

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For people with cancer:

Adults aged 18 or older who have been diagnosed with Head and Neck Cancer and are planning to receive immunotherapy treatment
People whose doctor has assessed their life expectancy to be at least 3 months
People who have a tissue biopsy available, or existing tissue test results for certain cancer markers (called PD-L1 TPS and/or PD-L1 CPS), held at the participating hospital

For healthy participants (no cancer):

Adults aged 18 or older who have never been diagnosed with any type of cancer

Who may not be able to join:

People who have a diagnosed psychiatric (mental health) disorder
People who have uncontrolled medical complications or other serious health conditions
People who have difficulty with blood draws, or who are unwilling to attend scheduled follow-up blood collection appointments
People whose doctor assesses them as unsuitable for participation in the study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Chang Gung Memorial Hospital

Registry

ClinicalTrials.gov

Start date

25 February 2025

Est. completion

31 December 2030

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

ICI responses, concordance to tissue PD-L1 expression

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov